Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Notes Payables (2017 - 2018)

Historic Notes Payables for Organogenesis Holdings (ORGO) over the last 2 years, with Q4 2018 value amounting to $15.9 million.

  • Organogenesis Holdings' Notes Payables fell 6.29% to $15.9 million in Q4 2018 from the same period last year, while for Dec 2018 it was $15.9 million, marking a year-over-year decrease of 6.29%. This contributed to the annual value of $15.9 million for FY2018, which is 6.29% down from last year.
  • As of Q4 2018, Organogenesis Holdings' Notes Payables stood at $15.9 million, which was down 6.29% from $15.9 million recorded in Q4 2017.
  • In the past 5 years, Organogenesis Holdings' Notes Payables registered a high of $15.9 million during Q4 2017, and its lowest value of $15.9 million during Q4 2018.